Ultragenyx Pharmaceutical | RARE - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Immunic USD 31.55M 290K 2026-09
Insmed USD 596.57M 157.83M 2026-09
Ionis Pharmaceuticals USD 435.29M 119.65M 2026-09
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Kyowa Hakko Kirin JPY 150.28B 32.11B 2026-09
MacroGenics USD 107.23M 1.58M 2026-09
Moderna USD 2.03B 506M 2026-09
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09